Torrent Pharma Derma Products

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 6080 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today we rank amongst the leaders in the therapeutic segments of Cardiovascular (CV) and Central Nervous System (CNS).We also have significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries.

The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing. Torrent Pharmaceuticals Ltd. Motorola symbol mc3090 driver. Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the. Derma Products Manufacturer.

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Right from pioneering niche marketing in India to earning the sobriquet of ‘the Company with the most first launches’, Torrent Pharma has always remained ahead of its competition.

Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network and a widespread global presence. It has three world-class manufacturing facilities at Indrad (Gujarat), Baddi (Himachal Pradesh) and Sikkim. The facilities are approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies.

A new facility is taking shape at Dahej SEZ in Western India, which will cater to the international markets. Torrent Pharma is the sole manufacturer of Insulin Formulations for Novo Nordisk in India since the early ‘90s and has also set up a dedicated formulation and packaging facility for Insulin. Source: Torrent Pharmaceuticals Ltd: Leader in the pharmaceutical industry 2015 Torrent Pharma recognized as the Most Promising Company of the Year at the 10th CNBC TV18 India Business Leader Awards 2014. 2014 Acquired Elder Pharma’s Indentified Indian Branded Formulation Business in India and Nepal. 2011 Forayed into oncology segment. 2006 The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got USFDA approval. 2000 Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility.

Updated: January, 2015. • • • • • • • • • • • • • • • • • • • • • • Copyright © 2010-2019 India Brand Equity Foundation All material, information, data, images or content on this website is subject to copyright or other applicable intellectual property laws and no part of it can be reproduced in any form (including paper or electronic form) without prior written consent and approval from IBEF. Infringements are subject to prosecution under the applicable laws.

Torrent

For consent related queries and conditions, please write to An initiative of the.